Cytomegalovirus Therapy
Leflunomide is possible alternative for gangciclovir sensitive and resistant CMV infection
Published in TB and Outbreaks Week, July 4th, 2006
"The search for newer more cost effective treatments for infectious diseases remains a challenge. Cytomegalovirus (CMV) infection, which is especially common in the immunosuppressed, is an important challenge for treating physicians," researchers in India report.
According to the authors, "Gangciclovir's cost is a major hurdle in developing countries. Leflunomide is cheaper and is easily given orally. It works by a novel mechanism inhibiting virion assembly.
"It also has immunosuppressive properties," and has "been shown to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- HIV/AIDS Ocular Syphilis
Ocular syphilis incidence high among HIV-infected patients receiving HAART - HIV/Tuberculosis Coinfection
Tuberculosis prevalence high in HIV-infected gold miners with low CD4 counts - Marburg Hemorrhagic Fever Vaccine
Replication-competent vaccine provides postexposure protection against Marburg virus - Sleeping Sickness
Sleeping sickness eliminated with intensive surveillance and treatment in Luba - Aspergillosis Diagnostics
Mucous plug microscopy optimal for Aspergillus tracheobronchitis diagnosis - Bacterial Meningitis
MMP-9 and MMP-8/-13 are upregulated in CSF during aseptic and bacterial meningitis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
